Refreshing results…
T-cell Lymphoma and Secondary Primary Malignancy Risk After Commercial CAR T-cell Therapy
UploadAuthor Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
UploadDecade-long leukaemia remissions with persistence of CD4+ CAR T cells
Download from www.nature.comThe Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma
UploadCRISPR-engineered T cells in patients with refractory cancer
UploadCAR T cell viability release testing and clinical outcomes: is there a lower limit?
UploadPersonalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer
UploadIbrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
Download from ashpublications.orgMissing publications? Search for publications with a matching author name.